- Home
- HESM vs IMVT Comparison
HESM vs IMVT Comparison
Compare HESM & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HESM
- IMVT
- Stock Information
- Founded
- HESM 2014
- IMVT N/A
- Country
- HESM United States
- IMVT United States
- Employees
- HESM N/A
- IMVT N/A
- Industry
- HESM Oil & Gas Production
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HESM Energy
- IMVT Health Care
- Exchange
- HESM Nasdaq
- IMVT Nasdaq
- Market Cap
- HESM 3.8B
- IMVT 4.2B
- IPO Year
- HESM N/A
- IMVT N/A
- Fundamental
- Price
- HESM $36.33
- IMVT $26.77
- Analyst Decision
- HESM Buy
- IMVT Strong Buy
- Analyst Count
- HESM 3
- IMVT 11
- Target Price
- HESM $38.67
- IMVT $48.10
- AVG Volume (30 Days)
- HESM 653.8K
- IMVT 799.9K
- Earning Date
- HESM 01-29-2025
- IMVT 02-10-2025
- Dividend Yield
- HESM 7.65%
- IMVT N/A
- EPS Growth
- HESM 16.31
- IMVT N/A
- EPS
- HESM 2.37
- IMVT N/A
- Revenue
- HESM $1,456,100,000.00
- IMVT N/A
- Revenue This Year
- HESM $12.56
- IMVT N/A
- Revenue Next Year
- HESM $11.40
- IMVT N/A
- P/E Ratio
- HESM $15.13
- IMVT N/A
- Revenue Growth
- HESM 11.43
- IMVT N/A
- 52 Week Low
- HESM $30.72
- IMVT $24.61
- 52 Week High
- HESM $39.11
- IMVT $45.58
- Technical
- Relative Strength Index (RSI)
- HESM 48.03
- IMVT 44.77
- Support Level
- HESM $35.53
- IMVT $26.19
- Resistance Level
- HESM $36.99
- IMVT $28.08
- Average True Range (ATR)
- HESM 0.84
- IMVT 1.01
- MACD
- HESM -0.14
- IMVT -0.03
- Stochastic Oscillator
- HESM 20.37
- IMVT 32.73
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).